Pivotal ABX464 clinical trials ongoing or planned for three indications: Ulcerative colitis, Crohn's disease and Covid-19 Four phase 1 studies...
HOUSTON--(BUSINESS WIRE)--#ASME--The American Society of Mechanical Engineers (ASME) has named Medistar Corporation as one of five 2020 Emerging Technology Award...
QliqSOFT Chatbot Technology to Power COVID-19 Vaccination Administration Support MOBILE, Ala.--(BUSINESS WIRE)--$CPSI--CPSI (NASDAQ: CPSI), a community healthcare solutions company, and...
TULSA, OK / ACCESSWIRE / December 9, 2020 / (OTC PINK:LVGI) Limitless Venture Group, Inc. ("LVGI" or "the Company") today...
CAVE CREEK, AZ / ACCESSWIRE / December 9, 2020 / Dr. Jeff Comer, a successful leader in the Alaska healthcare...
CHARLOTTESVILLE, VA / ACCESSWIRE / December 9, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on...
STUART, FL / ACCESSWIRE / December 9, 2020 / Prescription Hope, one of the largest patient assistance program administrators in...
Company Achieves Rare Milestone in Cannabis Industry DENVER, CO / ACCESSWIRE / December 9, 2020 / Leafbuyer Technologies, Inc. ("Leafbuyer"...
The Companies will work together to bring Chemesis' AI retail solution to Portland, Oregon VANCOUVER, BC / ACCESSWIRE / December...
aGvHD among potential indications being considered for next stage of development Candidate to move to IND-enabling studies in 2021 RALEIGH,...
Powered by Zylö's patented Xerogel Silica Gel ("Z-Pod™") delivery system, Grapefruit's Patented Hourglass™ THC + Cannabinoid Topical Cream is the...
MENLO PARK, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Broad and deep portfolio of highly differentiated product candidates aligned with needs of patients and doctorsRobust pipeline includes 4 development...
TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) is pleased to announce...
MONALEESA-7 median overall survival (OS) results reinforce Kisqali as the CDK4/6 inhibitor with unrivaled OS evidence1Kisqali plus endocrine therapy had...
– Data demonstrate potential of Amunix’s XPAT (XTENylated Protease-Activated T cell engager) platform to mitigate on-target, off-tumor toxicity that has...
Disease control and survival data is presented from the clinical trials of Bria-IMT™ alone or in combination with immune checkpoint...
FDA has granted clearance for the commencement of Phase 1 clinical trials of STI-2020 (COVI-AMGTM) in healthy volunteers and COVID-19...
–EDP1908 announced as clinical candidate in oncology after showing superior preclinical activity over EDP1503––Interim clinical data for EDP1503 suggest potential...
VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or...